As the federal funding agency responsible for investing in health research, CIHR has been central to Canada’s response to COVID-19.
In February 2020, CIHR issued a rapid research funding opportunity to accelerate the development, testing and implementation of medical and social countermeasures to mitigate the rapid spread of COVID-19 and its negative consequences on people and communities.
Through this process, and in collaboration with our federal and provincial partners, CIHR invested $55.3M in 99 research projects across the country. In June 2020, we invested another $109M to support a further 139 research projects.
This research spans everything from diagnostics and potential treatments to public health responses and communication strategies.
Since then, CIHR has continued to work with partners to invest in COVID-19 Canadian health research with dedicated funding for specific topics such as:
- Indigenous communities’ experiences with COVID-19;
- addressing the mental health and substance use challenges facing Canadians during the pandemic;
- how to keep residents and staff of long-term care homes safe from COVID-19; and
- developing guidelines related to prescribing and dispending opioids during the pandemic.
CIHR also has engaged with our international partners to ensure the alignment and coordination of Canada’s research with the international response.
COVID-19 and Mental Health
Initiative supporting the mental health of Canadians in the COVID-19 context.
COVID-19 and Indigenous Health
Funding opportunities, featured research, and culturally safe resources
Made in Canada
Celebrate Canadian success stories in the fight against COVID-19
- Date modified: